Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzymatic Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103667397B details enzymatic synthesis for high-purity intermediates. Offers cost reduction and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN109097409A reveals dual-product enzymatic route. High purity D-amino acids and alpha keto acids. Cost-effective supply chain solutions for global pharmaceutical manufacturing.
Novel catalytic route for posaconazole intermediate ensuring high purity and cost efficiency for pharmaceutical supply chains globally. This report analyzes patent CN115448911B for strategic sourcing.
Patent CN116848257A enables green production of (R)-mandelic acid. Achieve cost reduction in pharmaceutical intermediates manufacturing with sustainable enzyme cascades.
Patent CN105461606B details enzymatic hydrolysis for Ledipasvir intermediates. Achieve >99% de value and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN102181498B enzyme method ensures high purity omega-3 phosphatidylcholine with low pollution and scalable production for global nutritional ingredients suppliers.
Patent CN101045936B details a novel enzymatic resolution process using succinic anhydride, offering significant cost reduction and simplified purification for pharmaceutical intermediates.
Patent CN103773822B reveals streamlined Simvastatin production reducing steps and solvents for supply chain efficiency.
Patent CN1754963A details a solvent-free enzymatic route for pyroglutamic acid esters, offering high purity and cost-effective manufacturing for personal care suppliers.
Patent CN100404686C details enzymatic resolution of C-24 hydroxy vitamin D isomers, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel enzyme process for cefoxitin acid reduces waste and energy. Reliable supply chain for high-purity pharmaceutical intermediates with scalable manufacturing capabilities.
Novel enzymatic method for L-2-aminobutyric acid production. Low cost, high yield, scalable process for pharmaceutical intermediates and supply chain optimization.
Advanced enzymatic resolution synthesis for chiral antifungal intermediates. Cost-effective, scalable production of high-purity pharmaceutical ingredients with superior stereocontrol.
Patent CN118685390B reveals high-yield enzymatic route for DHA. Offers green manufacturing and supply chain stability for global pharmaceutical intermediate procurement strategies.
Patent CN114592027A reveals a novel two-step method for Tauroursodeoxycholic Acid production, offering significant cost reduction in API manufacturing and high-purity outcomes.
Novel enzyme mutant technology enables green cordycepin production. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN102250976A reveals an enzymatic route for chiral tert-leucine. Achieve >99% ee and significant cost reduction in pharmaceutical intermediate manufacturing with scalable green chemistry.
Novel lipase mutant enables efficient synthesis of chiral intermediates. Reduces solvent use and enhances supply chain reliability for global pharmaceutical manufacturing.
Patent CN115851863B reveals enzymatic route for spongane skeletons. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Patent CN114214375A details a novel enzymatic route for high-purity Ruxolitinib intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.